SMT and TALENT RCT in Europe

This video is offered by SMT


With over 800 patients enrolled in their randomised clinical trial, SMT is convinced of the safety and efficacy of their dependable Supraflex stent. Learn the basis for their confidence with A.G. Zaman, as he introduces this new-generation DES which is safe, flexible and perhaps non-inferior to the current workhorse stent. Early positive results from a single-centre UK registry data paved the way for the implementation of the current, all-comers trial. What do we know so far and can we make any assumption from early emerging data? Join us here and find out…